News

Novo Nordisk and Omeros Corporation have entered into a definitive agreement granting Novo Nordisk exclusive global rights to zaltenibart (formerly OMS906), a clinical-stage antibody…
Read More...

Adcytherix SAS, a French biopharmaceutical company developing next-generation antibody drug conjugates (ADCs), has closed a €105 million (US$122 million) Series A funding round — the…
Read More...

Minovia Therapeutics Ltd., a clinical-stage biotech company focused on mitochondrial disease therapies, announced that the U.S. Food and Drug Administration (FDA) has granted Orphan…
Read More...

Viatris Inc., a global healthcare company, has announced the acquisition of Aculys Pharma, Inc., a clinical-stage biopharmaceutical firm focused on innovative neurological treatments.…
Read More...

Avantor, Inc., a global leader in life sciences and advanced technology products, has announced a strategic partnership with BlueWhale Bio, a commercial-stage company focused on…
Read More...

Johnson & Johnson has announced plans to separate its Orthopaedics division into a standalone company, DePuy Synthes, as part of a strategic move to sharpen its focus on high-growth…
Read More...

BioCryst Pharmaceuticals announced it will acquire Astria Therapeutics in a cash-and-stock deal valued at approximately $700 million, aiming to expand its portfolio of treatments for…
Read More...

Nabla Bio, a biotechnology company using generative AI to design novel therapeutics, announced a major expansion of its partnership with global pharmaceutical company Takeda. The new…
Read More...

Pfizer Inc. announced positive topline results from its Phase 3 HER2CLIMB-05 trial, marking a potential breakthrough in first-line treatment for patients with HER2-positive (HER2+)…
Read More...

Jacobio Pharma (1167.HK) announced that its subsidiary, Beijing Jacobio Pharmaceuticals Co., Ltd., has signed a Capital Increase and Equity Transfer Agreement with Oceanpine Capital and…
Read More...

Clinical-stage biotech company SystImmune has dosed the first patient in a global registrational Phase 2/3 trial for its experimental cancer therapy izalontamab brengitecan (iza-bren),…
Read More...

AbbVie announced that the U.S. Food and Drug Administration (FDA) has approved a label expansion for RINVOQ (upadacitinib), broadening its use in the treatment of moderately to severely…
Read More...

The U.S. Food and Drug Administration (FDA) has approved UZEDY (risperidone) as a once-monthly, long-acting injectable for the maintenance treatment of bipolar I disorder (BD-I) in…
Read More...

Celltrion, Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved EYDENZELT® (aflibercept-boav), a biosimilar to EYLEA®, for the treatment of several major…
Read More...

Cidara Therapeutics has announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to its investigational drug CD388 for the prevention of…
Read More...

Boehringer Ingelheim has received approval from the U.S. Food and Drug Administration (FDA) for its new oral therapy, JASCAYD (nerandomilast), for the treatment of idiopathic pulmonary…
Read More...

Turbine, a biotechnology company specializing in AI-based virtual disease modeling, has announced a collaboration with AstraZeneca to enhance the discovery of antibody-drug conjugates…
Read More...

Werewolf Therapeutics has announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to its lead candidate WTX-124, a conditionally activated…
Read More...

The U.S. Food and Drug Administration (FDA) has approved Regeneron Pharmaceuticals' Libtayo® (cemiplimab-rwlc) as the first adjuvant immunotherapy for adult patients with cutaneous…
Read More...

Arthrosi Therapeutics, Inc., a late-stage biotechnology company focused on developing next-generation treatments for gout and tophaceous gout, has announced the successful closing of a…
Read More...